Major Component In Turmeric Spice Enhances Effect Of Chemo Drug For Head, NeckCancers
by
Ed H.Posted
Tue 19 Oct 2010 5:40pm
Curcumin, the major component in the spice turmeric, when combined with the chemotherapy drug Cisplatin, enhances the chemotherapy’s suppression of head and neckcancer... author, Dr. Marilene Wang, a UCLA professor of head and neck surgery and a Jonsson Cancer Center researcher.
“Head and neckcancers, particularly cases diagnosed in a later stage
Read on »
HPV 16 Linked to Head and NeckCancers in Study – Gardasil Vaccine Recommended
by
Medical QuackPosted
Thu 21 May 2009 10:42pm
are a bit scary with 70% of the population will be infected. Amazing that the research has lead to information that it could prevent head and neckcancers. BD
(PhysOrg.com... 16 to prevent head & neckcancers. The call comes amid growing evidence that certain cancers of the head and neck are strongly linked to HPV 16, a specific strain of the human
Read on »
PET surveillance for head and neckcancer
by
Mark LevinPosted
Sun 13 Dec 2009 8:08am
The question is about the appropriate followup of head and neckcancer. This is surveillance rather than restaging. NCCN on p. 42, to which one is directed by links from... in patients with treated head and neckcancer and available retrospective data are conflicting.
The detection of residual disease after therapy is a particularly difficult problem
Read on »
Coffee Might Guard Against Head, NeckCancers
by
nutrition.govPosted
Fri 18 Jun 2010 5:00am
HealthDay
By Robert Preidt
Friday, June 18, 2010
FRIDAY, June 19 (HealthDay News) -- Coffee may help protect against head and neckcancers, a new review finds.
Researchers analyzed nine studies collected by the International Head and NeckCancer Epidemiology consortium. They found that regular coffee drinkers (four
Read on »
Head and NeckCancer - Drug Pipeline Analysis and Market Forecasts to 2016
by
AarkstorePosted
Mon 19 Apr 2010 4:10am
The industry analysis specialist, has released its new report, “Head and NeckCancer - Drug Pipeline Analysis and Market Forecasts to 2016”. The report is an essential source of information and analysis on the global head and neckcancer market. The report identifies the key trends shaping and driving the global head and neckcancer market. It also provides
Read on »
Cisplatin etoposide for head and neckcancer
by
Mark LevinPosted
Tue 26 Oct 2010 1:56am
Cisplatin and etoposide has been reported for the treatment of recurrent head and neckcancer but it is not a well-supported regimen or one that has been popular over teh.... Goldine, J. M. Connors, K. Gelmon, M. A. Knowling Efficacy of weekly cisplatin-based chemotherapy in recurrent and metastatic head and neckcancer
Ann Oncol (1992) 3 (suppl 3
Read on »
Tarceva for head and neckcancer
by
Mark LevinPosted
Wed 25 Nov 2009 10:03pm
and neckcancer, for example, Study of RADPLAT and Tarceva in Locally Advanced Head and Neck Squamous Cell Carcinoma (SCCA), NCT00304278. The purpose of this study is to determine the safety and effectiveness of treatment with Tarceva (Erlotinib) and RADPLAT (RADiation and intraaterial cisPLATin) for patients with Head and Neckcancer. There is also: A Study
Read on »
Delay in diagnosis of head and neckcancer
by
Mark LevinPosted
Thu 01 Jul 2010 5:25am
Diagnosis and treatmetn of head and neckcancer is complex and requires co-ordination or providers and resources. Delays in diagnosis is not uncommon. In a Canadian study... cancers.J Can Dent Assoc. 2008 Feb;74(1):61
Goy J, Hall SF, Feldman-Stewart D, Groome PA. Diagnostic delay and disease stage in head and neckcancer: a systematic review
Read on »
Carboplatin for chemoradiation for head and neckcancer
by
Mark LevinPosted
Thu 13 Aug 2009 7:39pm
)-based induction chemotherapy for head and neckcancer and the case for sequential, combined-modality treatment.Oncologist. 2003;8(1):35-44.
nccn.org, head and neck
Eckardt...:11-3.
AGARWALA S. S. et al, Long-term outcomes with concurrent carboplatin, paclitaxel and radiation therapy for locally advanced, inoperable head and neckcancer Annals
Read on »
